We reasoned that this immune selection for IFNγR2 mutants would occur most robustly in the presence of a strong tumor-antigen-specific CD8+ T cell response, as the selection mechanism would involve direct tumor cell recognition of antigen. Here, CD8A is linked to neoplasm.